Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodoros Foukakis

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Cancers|June 10, 2022
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter StudyUna Kjällquist, Balazs Acs, Sara Margolin, et al.
IEEE Journal of Biomedical and Health Informatics|June 12, 2024
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology ImagesNikos Tsiknakis, Georgios Manikis, Evangelos Tzoras, et al.
Cancer Treatment Reviews|November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancerRupert Bartsch, David Cameron, Eva Ciruelos, et al.
NPJ Breast Cancer|March 3, 2021
Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiationKang Wang, Zhuyue Li, Xingxing Chen, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 6, 2006
Molecular markers for discrimination of benign and malignant follicular thyroid tumorsMårten Fryknäs, Ulrika Wickenberg-Bolin, Hanna Göransson, et al.
Breast (Edinburgh, Scotland)|May 10, 2025
Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter studyUna Kjällquist, Nikos Tsiknakis, Balazs Acs, et al.
Cancers|October 5, 2019
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast CancerIoannis Zerdes, Majken Wallerius, Emmanouil G Sifakis, et al.
Endocrine-Related Cancer|August 30, 2008
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinomaJia-Jing Lee, Amy Y M Au, Theodoros Foukakis, et al.
Molecular Oncology|June 19, 2021
Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancerKang Wang, Lun Li, Sebastià Franch-Expósito, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Cancers|June 10, 2022
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter StudyUna Kjällquist, Balazs Acs, Sara Margolin, et al.
IEEE Journal of Biomedical and Health Informatics|June 12, 2024
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology ImagesNikos Tsiknakis, Georgios Manikis, Evangelos Tzoras, et al.
Cancer Treatment Reviews|November 24, 2024
Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancerRupert Bartsch, David Cameron, Eva Ciruelos, et al.
NPJ Breast Cancer|March 3, 2021
Risk of hematologic malignancies after breast ductal carcinoma in situ treatment with ionizing radiationKang Wang, Zhuyue Li, Xingxing Chen, et al.
Breast Cancer Research : BCR|March 2, 2019
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursArian Lundberg, Linda S Lindström, Jingmei Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 6, 2006
Molecular markers for discrimination of benign and malignant follicular thyroid tumorsMårten Fryknäs, Ulrika Wickenberg-Bolin, Hanna Göransson, et al.
Breast (Edinburgh, Scotland)|May 10, 2025
Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter studyUna Kjällquist, Nikos Tsiknakis, Balazs Acs, et al.
Cancers|October 5, 2019
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast CancerIoannis Zerdes, Majken Wallerius, Emmanouil G Sifakis, et al.
Endocrine-Related Cancer|August 30, 2008
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinomaJia-Jing Lee, Amy Y M Au, Theodoros Foukakis, et al.
Molecular Oncology|June 19, 2021
Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancerKang Wang, Lun Li, Sebastià Franch-Expósito, et al.
Pageof 13